ロード中...
Five cases of BRAF V600E-mutant lung adenocarcinoma with high expression of programmed death ligand 1
We reported consecutive five patients with BRAF V600E-mutant recurrent or advanced non-small cell lung cancer who were identified between April 2016 and June 2019. All five patients had high programmed death ligand 1 (PD-L1) tumor proportion scores (50, 55, 75, 95 and 100%). Four of the five patient...
保存先:
| 出版年: | Respir Med Case Rep |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7218153/ https://ncbi.nlm.nih.gov/pubmed/32420017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101071 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|